Top Story

Anal cancer survival rates lowest in black men

August 17, 2017

New research has identified significant racial and sex-based disparities in survival among patients with locoregional squamous cell carcinoma of the anus, especially in black men, who showed the lowest survival rates.

Squamous cell carcinoma of the anus (SCCA), the most common histologic subtype of anal cancer, is one of the few cancers whose incidence is rising in the U.S., with an especially rapid increase seen in black men. This new study reveals that known disparities in the incidence of this cancer appear to also extend to survival.

SillaJen, NCI enter agreement to evaluate Pexa-Vec for advanced colorectal cancer

August 17, 2017
SillaJen and NCI entered a cooperative research and development agreement to evaluate Pexa-Vec for the treatment of patients with advanced colorectal cancer. SillaJen…
In the Journals Plus

Fusions define new colorectal cancer subtype with poor prognosis

August 16, 2017
Patients with ALK-, ROS1- or NTRK-rearranged tumors defined a rare subtype in metastatic colorectal cancer associated with poor outcomes, according to a study published…
In the Journals Plus

Advanced cancer stage at diagnosis increases blood clot risk

August 10, 2017
More advanced disease at the time of cancer diagnosis increased risk for venous thromboembolism, according to a study published in Journal of Thrombosis and
More Headlines »

The Patient with Hepatitis B

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with hepatitis B.
More »
GI Bookshelf

Chapter 9: Gastroduodenal Stents

From Self-Expanding Stents in Gastrointestinal Endoscopy
More »
Resource Centers
Biosimilars in the US

Biosimilars in the US

Meeting News Coverage

VIDEO: Lutathera 'an exciting new option for therapy' in midgut neuroendocrine tumors

January 29, 2016
More »